Topics
Glioblastoma | Treatment | Clinical trials | Extent of resection
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Extent of resection
Gerritsen JKW, Young JS, Chang SM, Krieg SM, Jungk C, van den Bent
MJ, Satoer DD, Ille S, Schucht P, Nahed BV, Broekman MLD, Berger
M, De Vleeschouwer S, Vincent AJPE.
SUPRAMAX-study:
supramaximal resection versus maximal resection for glioblastoma
patients: study protocol for an international multicentre
prospective cohort study (ENCRAM 2201).
BMJ
Open. 2024 Apr 29;14(4):e082274. doi:
10.1136/bmjopen-2023-082274. PMID:
38684246. Interventional study protocol. ˍ
Sonoda Y, Sekino Y, Mizusawa J, Shibahara I, Sasaki K, Sekita T,
Ichikawa M, Igaki H, Kinoshita M, Shibahara J, Ichimura K, Arakawa
Y, Fukuda H, Narita Y.
AB012. A phase
III randomized trial of gross total resection versus possible
resection of fluid-attenuated
inversion recovery (FLAIR) hyperintensity lesion
on magnetic resonance image for newly
diagnosed supratentorial glioblastoma
(JCOG2209).
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB012. doi:
10.21037/cco-24-ab012. PMID:
39295330. Interventional study. ˍ